Log in to save to my catalogue

Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis

Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_848318775

Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis

About this item

Full title

Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis

Publisher

London: London : Springer-Verlag

Journal title

Clinical rheumatology, 2011-02, Vol.30 (2), p.269-273

Language

English

Formats

Publication information

Publisher

London: London : Springer-Verlag

More information

Scope and Contents

Contents

Interleukin 17 (IL-17) is a Th17 cytokine associated with inflammation, autoimmunity, and defense against some bacteria; it has been implicated in many chronic autoimmune diseases including psoriasis, multiple sclerosis, and systemic sclerosis. However, whether IL-17 plays a role in the pathogenesis of ankylosing spondylitis (AS) remains unclear. T...

Alternative Titles

Full title

Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_848318775

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_848318775

Other Identifiers

ISSN

0770-3198

E-ISSN

1434-9949

DOI

10.1007/s10067-010-1647-4

How to access this item